Chinese medicine compound for treating lung cancer and manufacturing method thereof

Abstract

The invention relates to a Chinese medicine composition for treating lung cancer. The Chinese medicine composition comprises the following active pharmaceutical ingredients in portion by weight: 10 to 15 potions of dandelion, 4 to 10 potions of licorice, 20 to 25 potions of ginseng, 20 to 25 potions of giant knotweed, 3 to 10 portions of rhizoma zedoariae, 10 tp 15 portions of Houttuynia cordata Thunb, 15 to 18 portions of Draconis Resina, 5 to 7 portions of indigo, 3 to 5 portions of asarum, 5 to 15 portions of sealwort and 6 to 15 portions of medlar. The Chinese medicine composition is prepared as follows: extracting ginseng with 90 to 95 percent ethanol in a reflux mode; grinding Draconis Resina and asarum and screening Draconis Resina and asarum powder; boiling twice the other active pharmaceutical ingredients added with water; combining decoctions and filtering the mixed decoctions; adding an extract of ginseng and powder of Draconis Resina and asarum into a filtrate in turn with even mixing; condensing the mixture to form a paste; and making the past into various pharmaceutical preparation forms. The Chinese medicine composition achieves remarkable curative effect, improvement on immunity of human bodies and mild function, produces no toxic side effects and is simple in preparation process and low in price.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating lung cancer and a preparation method thereof, belonging to the technical field of medical science and technology. Background technique [0002] Lung cancer is the most common primary malignant tumor of the lung, and its morbidity and mortality are increasing year by year. The prognosis of early surgical treatment of lung cancer is better, but due to the lack of obvious symptoms, most patients are already in the middle and late stages when they are diagnosed, and they lose the opportunity for surgical treatment. Generally, they can only adopt radiotherapy and chemotherapy. Currently commonly used chemotherapeutic drugs are cisplatin, carboplatin, mitomycin, 5-fluorouracil, bleomycin, etc. Although they have a certain inhibitory effect on tumor cells, they have very large toxic and side effects and are harmful to normal cells and organs of the human body. It is extremely ha...

AI Technical Summary

Problems solved by technology

The prognosis of early surgical treatment of lung cancer is better, but due to the lack of obvious symptoms, most patients are already in the middle and late stages when they are diagnosed, and they lose the opportunity for surgical treatment. Generally, they can only adopt radiotherapy and chemotherapy.

Currently commonly used chemotherapeutic drugs are cisplatin, carboplatin, mitomycin, 5-fluorouracil, bleomycin, etc. Although they have a certain inhibitory effect on tumor cells, they have very large toxic and side effects and are harmful to normal cells and organs of the human body. It is extremely harmful and seriously affects the quality of life of cancer patients

In recent years, people pay more and more attention to the application of traditional Chinese medicine in anti-cancer, such as cantharidin, ganoderma lucidum, etc., but when used alone, the content of active ingredients is low, the onset of effect is slow, and the effect is not very good ideal